1950
DOI: 10.1042/bj0470158
|View full text |Cite
|
Sign up to set email alerts
|

Studies on suramin. 9. The action of the drug on some enzymes

Abstract: Evidence is available that suramin inhibits a few enzymes (for a review of the literature see Town, Wills, Wilson & Wormall, 1950). For reasons given in the preceding paper we have studied the action of very small amounts of the drug on a considerable number of enzymes under conditions as closely related as possible to the physiological. This paper is concerned mainly with experiments on non-proteolytic enzymes, with a few observations on the milk-clotting enzymes.The primary object of the experiments describ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
21
1

Year Published

1960
1960
1994
1994

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(23 citation statements)
references
References 12 publications
1
21
1
Order By: Relevance
“…An interaction of cibacron blue and suramin with ATPase or GTPase enzymes important in either the transduction of purinoceptor-mediated responses or the metabolism of the agonist, could cause augmentation of responses to oj-methylene ATP (Wills & Wormall, 1950;Butler et al, 1988;Hourani & Chown, 1989). However, no definitive evidence to support any of these hypotheses was obtained in the present study and therefore the mechanism(s) underlying this phenomenon remains unclear.…”
Section: Discussioncontrasting
confidence: 55%
“…An interaction of cibacron blue and suramin with ATPase or GTPase enzymes important in either the transduction of purinoceptor-mediated responses or the metabolism of the agonist, could cause augmentation of responses to oj-methylene ATP (Wills & Wormall, 1950;Butler et al, 1988;Hourani & Chown, 1989). However, no definitive evidence to support any of these hypotheses was obtained in the present study and therefore the mechanism(s) underlying this phenomenon remains unclear.…”
Section: Discussioncontrasting
confidence: 55%
“…Suramin also selectively and competitively inhibits the effects of ATP on PC12 phaeochromocytoma cells with similar potency, the reported pA2 value being 4.52 (Nakazawa et al, 1990;Inoue et al, 1991). As well as antagonizing P2-purinoceptors, suramin is also known to inhibit a number of other proteins with nucleotide binding sites, for example yeast hexokinase (Wills & Wormall, 1950), erythrocyte membrane Na+/K+-ATPase (Fortes et al, 1973), firefly luciferase (Fortes et al, 1973), vacuole-type H+-ATPases (Moriyama & Nelson, 1988;Calcaterra et al, 1988), smooth muscle ectonucleotidases (Hourani & Chown, 1989), protein kinase C (Mahoney et al, 1990), mitochondrial adenine nucleotide exchanger (Calcaterra et al, 1988), the GTPase activity associated with Gi (Butler et al, 1988) and various polynucleotide synthesizing enzymes (Broder et al, 1985;Ono et al, 1988;Offensperger et al, 1988).…”
Section: Introductionmentioning
confidence: 97%
“…This may reflect the ability of the drug to inhibit ectonucleotidases responsible for the breakdown of ATP (Hourani & Chown, 1989). Suramin inhibited the effects of histamine and 5-HT perhaps as a result of the ability to bind a protein (Wills & Wormall, 1950) including those of receptor sites. While the responses to NA and KCI were unaffected by the drug, suramin seems insufficiently selective to be useful in the study of co-transmission in this tissue.…”
Section: Alteration Ofexternal Ionic Environmentmentioning
confidence: 99%